Previous Article | Next Article ![]()
Journal of Virology, December 2000, p. 11115-11120, Vol. 74, No. 23
Department of Pathology and Immunology,
Washington University School of Medicine, St. Louis, Missouri 63110
Received 1 June 2000/Accepted 30 August 2000
Epstein-Barr virus (EBV) nuclear antigen (EBNA) 2 (EBNA2) is
involved in upregulating the expression of both EBNAs and
latency-associated membrane proteins. Transcription of the six EBNA
genes, which are expressed in EBV-immortalized primary B cells, arises
from one of two promoters, Cp and Wp, located near the left end of the
viral genome. Wp is exclusively used to drive EBNA gene transcription during the initial stages of infection in primary B cells; induction of
transcription from Cp follows. We previously have mapped an EBNA2-dependent enhancer upstream of Cp (M. Woisetschlaeger et al.,
Proc. Natl. Acad. Sci. USA 88:3942-3946, 1991) and, more recently,
have demonstrated that deletion of this enhancer results in
EBV-immortalized lymphoblastoid cell lines (LCLs) that are heavily
biased toward the use of Wp to drive transcription of the EBNA genes
(L. Yoo et al., J. Virol. 71:9134-9142, 1997). To assess the
immortalizing capacity of this mutant EBV and to monitor the early
events after infection of primary B cells, B cells isolated from
cottontop marmosets were used to generate LCLs immortalized with the Cp
EBNA2 enhancer deletion mutant virus. As previously reported, all
EBV-infected marmoset LCLs examined could be triggered to produce
significant levels of virus. Infection of human B cells with wild-type
or Cp EBNA2 enhancer mutant viruses recovered from marmoset B-cell
lines demonstrated that (i) the Cp EBNA2 enhancer mutant virus
immortalizes primary human B cells nearly as efficiently as wild-type
virus and (ii) the Cp EBNA2-dependent enhancer plays an important role
in the induction of Cp activity during the early stages of infection.
The latter is consistent with the phenotype of LCLs immortalized with
the Cp EBNA2 enhancer mutant EBV. Finally, using an established LCL in
which EBNA2 function is regulated by
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Determining the Role of the Epstein-Barr Virus Cp
EBNA2-Dependent Enhancer during the Establishment of Latency by
Using Mutant and Wild-Type Viruses Recovered from Cottontop Marmoset
Lymphoblastoid Cell Lines
-estradiol, we showed that the
loss of EBNA2 function results in an ~4-fold decrease in the
steady-state levels of Cp-initiated transcripts and a concomitant
increase in the steady-state levels of Wp-initiated transcripts. Taken
together, these results provide strong evidence that EBNA2 plays an
important role in regulating Cp activity. These results also
demonstrate that diminished induction of Cp activity does not appear to
affect the ability of EBV to immortalize primary B cells in cultures. Finally, as shown here, infection of marmoset B cells with
immortalization-competent mutants of EBV provides a convenient
reservoir for the production of mutant viruses.
*
Corresponding author. Mailing address: Department of
Pathology, Box 8118, 660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-0367. Fax: (314) 362-4096. E-mail:
speck{at}pathology.wustl.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»